Mechanism of Amino Acid-Induced Skeletal Muscle Insulin Resistance in Humans
- Michael Krebs1,
- Martin Krssak1,
- Elisabeth Bernroider1,
- Christian Anderwald1,
- Attila Brehm1,
- Martin Meyerspeer12,
- Peter Nowotny1,
- Erich Roth3,
- Werner Waldhäusl1 and
- Michael Roden1
- 1Division of Endocrinology and Metabolism, Department of Internal Medicine III, University of Vienna Medical School, Vienna, Austria
- 2NMR-Group, Institute of Medical Physics, University of Vienna Medical School, Vienna, Austria
- 3Department of Surgery, University of Vienna Medical School, Vienna, Austria
Abstract
Plasma concentrations of amino acids are frequently elevated in insulin-resistant states, and a protein-enriched diet can impair glucose metabolism. This study examined effects of short-term plasma amino acid (AA) elevation on whole-body glucose disposal and cellular insulin action in skeletal muscle. Seven healthy men were studied for 5.5 h during euglycemic (5.5 mmol/l), hyperinsulinemic (430 pmol/l), fasting glucagon (65 ng/l), and growth hormone (0.4 μg/l) somatostatin clamp tests in the presence of low (∼1.6 mmol/l) and increased (∼4.6 mmol/l) plasma AA concentrations. Glucose turnover was measured with d-[6,6-2H2]glucose. Intramuscular concentrations of glycogen and glucose-6-phosphate (G6P) were monitored using 13C and 31P nuclear magnetic resonance spectroscopy, respectively. A ∼2.1-fold elevation of plasma AAs reduced whole-body glucose disposal by 25% (P < 0.01). Rates of muscle glycogen synthesis decreased by 64% (180–315 min, 24 ± 3; control, 67 ± 10 μmol · l−1 · min−1; P < 0.01), which was accompanied by a reduction in G6P starting at 130 min (ΔG6P260–300 min, 18 ± 19; control, 103 ± 33 μmol/l; P < 0.05). In conclusion, plasma amino acid elevation induces skeletal muscle insulin resistance in humans by inhibition of glucose transport/phosphorylation, resulting in marked reduction of glycogen synthesis.
Footnotes
-
Address correspondence and reprint requests to Michael Roden, MD, Division of Endocrinology and Metabolism, Department of Internal Medicine III, University of Vienna Medical School, Währinger Gürtel 18-20, A-1090 Vienna, Austria. E-mail: michael.roden{at}akh-wien.ac.at.
Received for publication 18 September 2001 and accepted in revised form 26 November 2001.
AA, amino acid; APE, atom percent excess; EGP, endogenous glucose production; FFA, free fatty acid; G6P, glucose-6-phosphate; GIR, glucose infusion rate; HPLC, high-performance liquid chromatography; NMR, nuclear magnetic resonance; PCr, phosphocreatine; Pi, inorganic phosphate; Ra, rate of glucose appearance; Rd, rate of glucose disappearance; RIA, radioimmunoassay.
- DIABETES














